The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 trial of trastuzumab rezetecan vs standard of care (SOC) for chemotherapy-refractory, HER2-positive, advanced colorectal cancer (CRC).
 
Jin Li
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Xiuying Xiao
No Relationships to Disclose
 
Yudong Wang
No Relationships to Disclose
 
Fengbin Zhang
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Qiu Meng
No Relationships to Disclose
 
Hong Zong
No Relationships to Disclose
 
Yigui Chen
No Relationships to Disclose
 
Xiang Gao
No Relationships to Disclose
 
Jun Zhou
No Relationships to Disclose
 
Xiaotong Li
Employment - Jiangsu Hengrui Pharmaceuticals
 
Yifan Shen
Employment - Jiangsu Hengrui Pharmaceuticals
 
Ning Dou
Employment - Jiangsu Hengrui Pharmaceuticals
 
Chuanpei Huang
Employment - Jiangsu Hengrui Medicine